BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 5, 2026
Home » Authors » Catherine Hollingsworth

Articles by Catherine Hollingsworth

Morphosys Pairs Antibody Platform with Sloning's

Oct. 8, 2010
By Catherine Hollingsworth

NewCo News: Tivorsan Ready to Raise Funds for Biglycan DMD Candidate

Oct. 7, 2010
By Catherine Hollingsworth

Cyclacel Seeks to Raise $22M for Phase III-Ready AML Drug

Oct. 6, 2010
By Catherine Hollingsworth

SPA in Hand, Onconova Moves Estybon into MDS Phase III

Oct. 5, 2010
By Catherine Hollingsworth

AVEO Regains Rights to Phase II Antibody AV-299

Oct. 1, 2010
By Catherine Hollingsworth

MAP Raising $40.9M as Levadex Heads Toward NDA

Sep. 30, 2010
By Catherine Hollingsworth

Researcher's Pet Project Leads to Eye Therapy, Lasker Prize

Sep. 29, 2010
By Catherine Hollingsworth

VaxDesign to be Acquired by Sanofi Pasteur in $60M Deal

Sep. 28, 2010
By Catherine Hollingsworth

Cylene Adds $12M to Top Off Substantial Series C Round

Sep. 24, 2010
By Catherine Hollingsworth

Sanofi-Vical's Gene Therapy Flames Out in Phase III Trial

Sep. 23, 2010
By Catherine Hollingsworth
Previous 1 2 3 4 5 6 7 8 9 … 64 65 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2026.
  • AI-generated image for brain organoid neural research

    CINP 2026: organoids reveal autism and addiction mechanisms

    BioWorld Science
    At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists

    BioWorld Science
    Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing